Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-01-02 @ 5:31 AM
Study NCT ID:
NCT01102335
Status:
UNKNOWN
Last Update Posted:
2010-04-13
First Post:
2010-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy
Sponsor:
Fudan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LCI-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Professor Jing-lin Xia
Old Organization:
Liver Cancer Institute